Phapros (PEHA) Net Profit Surges 311.58%: What Drove the Increase
Jakarta, CNBC Indonesia — State-owned pharmaceutical issuer PT Phapros Tbk (PEHA) recorded net profit of Rp31.60 billion in the third quarter of 2026, a surge of 311.58%. Sales grew 15.07% year on year to Rp786.57 billion.
The company also improved its operational efficiency. Earnings before interest, taxes, depreciation and amortisation (EBITDA) for January-September 2026 rose 30.26% to Rp117.66 billion compared with the same period in 2025. The EBITDA margin increased to 15% from 13.2%, indicating that Phapros’s production operations were becoming more efficient and its profitability stronger.
Phapros also reported sales of Rp940.88 billion, up 26.34% year on year. The positive trend continued through September 2026, with sales of Rp786.57 billion compared with Rp683.58 billion in January-September 2025.
The company also maintained cost efficiency, keeping its cost of goods sold (COGS) under control amid rupiah exchange-rate fluctuations. COGS in the first nine months of 2026 was Rp384.04 billion, an increase of just 11.04% from Rp345.86 billion in the same period last year. The COGS-to-sales ratio fell to 48.8% from 50.6%, indicating more efficient production.
Sales growth and operational efficiency lifted gross profit by 19.19% to Rp402.53 billion from Rp337.72 billion. The gross profit margin rose to 51.2% from 49.4%.
PT Phapros president director Intan Abdams Katoppo said the company’s performance growth through September 2026 stemmed from the effective execution of its strategy: strengthening working capital, applying more measured cost controls, reinforcing its product and business portfolio, and transforming its business systems and processes. The initiatives began in 2025 and continue to be assessed and reviewed periodically.
“We are optimistic that Phapros’s positive financial performance will continue through the end of this year. The increase in the EBITDA margin shows that our operations are becoming more efficient and, of course, our profitability is strengthening,” Intan said, as quoted on Monday (2 November 2026).
Phapros’s operating profit rose 55.90% to Rp80.97 billion from Rp51.94 billion in the same period of 2025. Pre-tax profit increased 233.59%, or more than threefold, to Rp48.65 billion from Rp14.58 billion in January-September 2025.
Net cash flow from operating activities rose 142.85% to Rp129.96 billion from Rp53.51 billion. Cash and cash equivalents as at 30 September 2026 increased 70.54% to Rp157.54 billion from Rp92.38 billion as at 30 September 2025. Total assets rose 4.74% to Rp1.45 trillion from Rp1.39 trillion as at 31 December 2025.
Source: jawawa.id (https://jawawa.id/newsitem/phapros-peha-net-profit-surges-311-58-what-drove-the-increase-1793598643)
Originally published by CNBC Indonesia (https://www.cnbcindonesia.com/market/20261102094852-17-781420/laba-bersih-phapros--peha--melonjak-31158-penyebabnya-terungkap), translated from Indonesian